67
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

High‐dose, short‐term, anti‐inflammatory treatment with dexamethasone reduces growth and augments the effects of 5‐fluorouracil on dimethyl‐α‐benzanthracene‐induced mammary tumors in rats

, , , , &
Pages 477-486 | Received 31 Jan 2006, Accepted 04 Apr 2006, Published online: 08 Jul 2009
 

Abstract

Objective. To evaluate the effects of dexamethasone (DXM) alone or in combination with 5‐fluorouracil (5‐FU) on dimethyl‐α‐benzanthracene (DMBA)‐induced mammary tumors in rats. Material and methods. Female Sprague‐Dawley rats were divided into 4 groups receiving: 1) saline (controls), 2) DXM (3 mg/kg), 3) 5‐FU (1.5 mg/kg) and 4) DXM and 5‐FU combined. The drugs were given i.p. every day for 4 days. Interstitial fluid pressure (Pif) and tumor growth were determined in all tumors on days 1, 5 and 7 using the “wick‐in‐the needle” technique and by external size measurements, respectively. Vessel density and inflammatory cell infiltration of tumor tissue were analyzed by immunohistochemistry. Results. DXM treatment significantly retarded tumor growth and reduced Pif. Treatment with a combination of DXM and 5‐FU reduced tumor size significantly more than any of the agents alone (p<0.01–0.001). Enhanced uptake of 5‐FU by DXM treatment was demonstrated by microdialysis. There were no differences in the density of CD31‐positive vessels after DXM or 5‐FU treatment, but inflammatory cell infiltration of tumor tissue was significantly reduced after DXM treatment. Conclusions. Our data suggest that DXM may be beneficial as an adjuvant to chemotherapy in the treatment of mammary cancer by increasing the uptake of 5‐FU in the tumor.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.